Case Moderators

Antonio Amodeo, MD, Bambino Gesù Children Hospital, Rome, Italy
Jennifer Conway, MD, Stollery Children’s Hospital/University of Alberta, Edmonton, Canada
Martin Schweiger, MD, PhD, Children’s Hospital Zurich, Zurich, Switzerland
Christina J. VanderPluym, MD, Boston Children’s Hospital, Harvard School of Medicine, Boston, MA, USA

Case Discussants

Lara Danziger-Isakov, MD, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
Lucas Eastaugh, MD, The Royal Hospital of Melbourne, Melbourne, Australia
Pirooz Eghtesady, MD, St. Louis Children’s Hospital, Washington University, St. Louis, MI, USA
Matthew O’Connor, MD, Children’s Hospital of Pennsylvania, Philadelphia, PA, USA

The pediatrics Master’s class will be focused on the use of mechanical support in more complex scenarios. Providers will be also be able to discuss and share best practice for device and patient selection. In addition, there will be discussion regarding the complications that can occur and the best ways to prevent and treat them.

This course is intended for members with higher levels of expertise (completed the core curriculum course on MCS and/or primary practice in MCS > 5 years). The target healthcare professionals would be pediatric cardiac surgeons, pediatric cardiologists, pediatric pulmonologists with pulmonary hypertension or advanced lung failure expertise, pediatric intensivists, pediatric anesthesiologists, pediatric ICU and cardiology nurses, perfusionists, VAD coordinators and VAD teams. While all members are invited to enroll, Master Classes are primarily designed to be of benefit for health care professionals who are beyond the training stages of their careers. This may be professionals who are seeking additional proficiencies, who wish to understand current areas of controversy, or who desire an update on the current advanced topics of the field. The information presented is intended to provide insights beyond core competencies established in the specialty.

After completion of this Class, participants will have improved competence and professional performance in their ability to:
 

1. To recognize bleeding and clotting challenges and the appropriate therapy
2. To identify the unique challenges in congenital patients with MCS support
3. To understand the potential complications and the management during MCS support
4. Identify the different mechanical support options in patients with pulmonary hypertension.

Physicians
Accreditation Statement – The International Society for Heart and Lung Transplantation (ISHLT) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement – ISHLT designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and Pharmacists
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISHLT. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 4.25 contact hours for nurses and 2.25 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.

Current guidelines state that participants in CME activities must be made aware of any affiliation or financial interest that may affect the program content or a speaker’s presentation. Planners, Faculty and Chairs participating in this meeting are required to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentations or service as Chair/Planner. Please refer to the Participant Notification document for a list of all disclosures. Additionally, all speakers have been asked to verbally disclose at the start of their presentation if a product they are discussing is not labeled for the use under discussion or is still investigational.